Sabra Healthcare REIT, Inc. $SBRA Stake Lowered by Bank of New York Mellon Corp

Bank of New York Mellon Corp reduced its stake in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 17.3% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 3,339,245 shares of the real estate investment trust’s stock after selling 700,210 shares during the period. Bank of New York Mellon Corp’s holdings in Sabra Healthcare REIT were worth $63,245,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Rothschild Investment LLC grew its holdings in shares of Sabra Healthcare REIT by 164.6% during the 4th quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust’s stock valued at $27,000 after acquiring an additional 889 shares in the last quarter. Founders Capital Management purchased a new position in shares of Sabra Healthcare REIT during the 3rd quarter valued at $28,000. Strengthening Families & Communities LLC acquired a new stake in shares of Sabra Healthcare REIT in the 4th quarter valued at $29,000. Danske Bank A S acquired a new stake in shares of Sabra Healthcare REIT in the 3rd quarter valued at $30,000. Finally, Larson Financial Group LLC lifted its stake in shares of Sabra Healthcare REIT by 42.3% in the 3rd quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust’s stock valued at $35,000 after purchasing an additional 553 shares during the last quarter. 99.40% of the stock is currently owned by hedge funds and other institutional investors.

Sabra Healthcare REIT Stock Performance

NASDAQ:SBRA opened at $18.90 on Wednesday. The firm’s 50-day moving average is $20.10 and its 200-day moving average is $19.69. Sabra Healthcare REIT, Inc. has a 52-week low of $17.17 and a 52-week high of $21.28. The company has a debt-to-equity ratio of 0.96, a quick ratio of 4.72 and a current ratio of 4.72. The company has a market cap of $4.77 billion, a price-to-earnings ratio of 30.00, a PEG ratio of 1.35 and a beta of 0.64.

Sabra Healthcare REIT (NASDAQ:SBRA) last posted its quarterly earnings data on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.16. Sabra Healthcare REIT had a net margin of 19.22% and a return on equity of 5.60%. The company had revenue of $211.74 million for the quarter, compared to the consensus estimate of $209.20 million. During the same quarter in the previous year, the firm posted $0.37 EPS. The business’s revenue was up 20.9% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Equities research analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.51 earnings per share for the current year.

Sabra Healthcare REIT Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, May 29th. Stockholders of record on Friday, May 15th were issued a dividend of $0.30 per share. The ex-dividend date was Friday, May 15th. This represents a $1.20 annualized dividend and a dividend yield of 6.3%. Sabra Healthcare REIT’s payout ratio is presently 190.48%.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on the stock. Citigroup lifted their price objective on shares of Sabra Healthcare REIT from $21.00 to $24.00 and gave the company a “buy” rating in a research note on Wednesday, February 18th. Truist Financial lifted their price objective on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “hold” rating in a research note on Friday, March 13th. Scotiabank lifted their price objective on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “sector perform” rating in a research note on Thursday, May 21st. Wells Fargo & Company lifted their price objective on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the company an “overweight” rating in a research note on Monday, June 1st. Finally, Cantor Fitzgerald lifted their price objective on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “neutral” rating in a research note on Monday, May 11th. Five equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to MarketBeat, Sabra Healthcare REIT has a consensus rating of “Moderate Buy” and an average target price of $22.40.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.